3 results on '"Ming Liang Oon"'
Search Results
2. The contribution of MYC and PLK1 expression to proliferative capacity in diffuse large B-cell lymphoma
- Author
-
Wee Joo Chng, Susan Swee-Shan Hue, Shuangyi Fan, Soo Yong Tan, Michal Marek Hoppe, Siok Bian Ng, Sanjay de Mel, Li M Poon, Hian Leng Chan, Hoang M Phuong, Anand D. Jeyasekharan, Shi Wang, Joanne Lee, Yen Lin Chee, Xin Liu, and Ming Liang Oon
- Subjects
Cancer Research ,Cell Cycle Proteins ,Biology ,Protein Serine-Threonine Kinases ,PLK1 ,Proto-Oncogene Proteins c-myc ,03 medical and health sciences ,0302 clinical medicine ,immune system diseases ,hemic and lymphatic diseases ,Proto-Oncogene Proteins ,medicine ,Image Processing, Computer-Assisted ,Humans ,Kinome ,In Situ Hybridization, Fluorescence ,Cell Proliferation ,Proliferative capacity ,Hematology ,medicine.disease ,Immunohistochemistry ,Lymphoma ,Ki-67 Antigen ,Oncology ,030220 oncology & carcinogenesis ,Cancer research ,Lymphoma, Large B-Cell, Diffuse ,Diffuse large B-cell lymphoma ,Software ,030215 immunology - Abstract
Polo-like kinase-1 (PLK1) regulates the MYC-dependent kinome in aggressive B-cell lymphoma. However, the role of PLK1 and MYC toward proliferation in diffuse large B-cell lymphoma (DLBCL) is unknown. We use multiplexed fluorescent immunohistochemistry (fIHC) to evaluate the co-localization of MYC, PLK1 and Ki67 to study their association with proliferation in DLBCL. The majority (98%, 95% CI 95-100%) of MYC/PLK1-double positive tumor cells expressed Ki67, underscoring the key role of the MYC/PLK1 circuit in proliferation. However, only 38% (95% CI 23-40%) and 51% (95% CI 46-51%) of Ki67-positive cells expressed MYC and PLK1, respectively. Notably, 40% (95% CI 26-43%) of Ki67-positive cells are MYC- and PLK-negative. A stronger correlation exists between PLK1 and Ki67 expression (
- Published
- 2019
3. T-Cell Lymphoma Clonality by Copy Number Variation Analysis of T-Cell Receptor Genes
- Author
-
Zi Wei Wong, Chee-Leong Cheng, Soo Yong Tan, Zhenhua Li, Tae-Hoon Chung, Jing Quan Lim, Shangying Chen, Allen Eng Juh Yeoh, Joseph D. Khoury, Shigeo Nakamura, Evelyn Huizi Lim, Ming Liang Oon, Shih-Sung Chuang, Wee Joo Chng, Gwyneth Soon, Siok Bian Ng, Soon Thye Lim, Olaf Rötzschke, Kenneth Hon Kim Ban, Bernett Lee, Yong-Howe Ho, Seiichi Kato, Sai Mun Leong, Emiko Takahashi, Choon Kiat Ong, Rex Au-Yeung, Claudio Tripodo, Oon M.L., Lim J.Q., Lee B., Leong S.M., Soon G.S., Wong Z.W., Lim E.H., Li Z., Juh Yeoh A.E., Chen S., Kim Ban K.H., Chung T.-H., Tan S.-Y., Chuang S.-S., Kato S., Nakamura S., Takahashi E., Ho Y.-H., Khoury J.D., Au-Yeung R.K.H., Cheng C.-L., Lim S.-T., Chng W.-J., Tripodo C., Rotzschke O., Ong C.K., and Ng S.-B.
- Subjects
0301 basic medicine ,clone (Java method) ,Cancer Research ,clonality ,Biology ,lcsh:RC254-282 ,Article ,03 medical and health sciences ,0302 clinical medicine ,medicine ,T-cell lymphoma ,T-cell receptor ,Copy-number variation ,copy number variation analysis ,Gene ,Whole genome sequencing ,whole genome sequencing ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,medicine.disease ,Molecular biology ,030104 developmental biology ,Oncology ,030220 oncology & carcinogenesis ,T-Cell Receptor Gene ,Monoclonal ,Clonality, Copy number variation analysis, T-cell lymphoma, T-cell receptor, Whole genome sequencing - Abstract
Simple Summary T-cells defend the human body from pathogenic invasion via specific recognition by T-cell receptors (TCRs). The TCR genes undergo recombination (rearrangement) in a myriad of possible ways to generate different TCRs that can recognize a wide diversity of foreign antigens. However, in patients with T-cell lymphoma (TCL), a particular T-cell becomes malignant and proliferates, resulting in a population of genetically identical cells with same TCR rearrangement pattern. To help diagnose patients with TCL, a polymerase chain reaction (PCR)-based assay is currently used to determine if neoplastic cells in patient samples are of T-cell origin and bear identical (monoclonal) TCR rearrangement pattern. Herein, we report the application of a novel segmentation and copy number computation algorithm to accurately identify different TCR rearrangement patterns using data from the whole genome sequencing of patient materials. Our approach may improve the diagnostic accuracy of TCLs and can be similarly applied to the diagnosis of B-cell lymphomas. Abstract T-cell lymphomas arise from a single neoplastic clone and exhibit identical patterns of deletions in T-cell receptor (TCR) genes. Whole genome sequencing (WGS) data represent a treasure trove of information for the development of novel clinical applications. However, the use of WGS to identify clonal T-cell proliferations has not been systematically studied. In this study, based on WGS data, we identified monoclonal rearrangements (MRs) of T-cell receptors (TCR) genes using a novel segmentation algorithm and copy number computation. We evaluated the feasibility of this technique as a marker of T-cell clonality using T-cell lymphomas (TCL, n = 44) and extranodal NK/T-cell lymphomas (ENKTLs, n = 20), and identified 98% of TCLs with one or more TCR gene MRs, against 91% detected using PCR. TCR MRs were absent in all ENKTLs and NK cell lines. Sensitivity-wise, this platform is sufficiently competent, with MRs detected in the majority of samples with tumor content under 25% and it can also distinguish monoallelic from biallelic MRs. Understanding the copy number landscape of TCR using WGS data may engender new diagnostic applications in hematolymphoid pathology, which can be readily adapted to the analysis of B-cell receptor loci for B-cell clonality determination.
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.